Top

World Journal of Urology

Published in:

01-12-2019 | Letter to Editor

A specific scoring system able to predict the efficacy of the therapy for bladder cancer: why not?

Author: Fabrizio Dal Moro

Published in: World Journal of Urology | Issue 12/2019

Excerpt

Dear Editor, …

Soria F, Krabbe LM, Todenhöfer T, Dobruch J, Mitra AP, Inman BA, Gust KM, Lotan Y, Shariat SF (2018) Molecular markers in bladder cancer. World J Urol. https://doi.org/10.1007/s00345-018-2503-4 CrossRefPubMedPubMedCentral

Dal Moro F, Valotto C, Guttilla A, Zattoni F (2013) Urinary markers in the everyday diagnosis of bladder cancer. Urologia 80:265–275. https://doi.org/10.5301/urologia.5000041 CrossRef

Dal Moro F, Rossi A, Zattoni F (2013) Does age really matter in the choice of treatment for bladder cancer? Br J Cancer 108:2415–2416. https://doi.org/10.1038/bjc.2013.239 CrossRef

Dal Moro F, Bovo A, Crestani A, Vettor R, Gardiman MP, Zattoni F (2015) Effect of hypertension on outcomes of high-risk patients after BCG-treated bladder cancer: a single-institution long follow-up cohort study. Medicine (Baltimore) 94:e589. https://doi.org/10.1097/MD.0000000000000589 CrossRef

Title: A specific scoring system able to predict the efficacy of the therapy for bladder cancer: why not?
Author: Fabrizio Dal Moro
Publication date: 01-12-2019
Publisher: Springer Berlin Heidelberg
Published in: World Journal of Urology / Issue 12/2019
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-018-2533-y

2024 ASCO Annual Meeting

Springer Medicine

A specific scoring system able to predict the efficacy of the therapy for bladder cancer: why not?

Excerpt

2024 ASCO Annual Meeting

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 12/2019

Utility of the EORTC risk tables and CUETO scoring model for predicting recurrence and progression in non-muscle-invasive bladder cancer patients treated with routine second transurethral resection

Oligorecurrent prostate cancer limited to lymph nodes: getting our ducks in a row

The impact of completeness of last transurethral resection of bladder tumors on the outcomes of radical cystectomy

Treatment of the primary tumor in metastatic prostate cancer

External validation of a nomogram for the prediction of 10-year life expectancy in candidates for radical prostatectomy

Is there enough evidence to support sacral neuromodulation as a viable treatment option in children and adolescents with neurogenic lower urinary tract dysfunction?